Melanoma Institute Australia

North Sydney 2065

0 studies enrolling now · 2 studies all time

What they study most

Melanoma, Melanoma (Skin), Melanoma Stage III, Melanoma Stage IV, Solid Tumors Harboring a BRAF V600 Mutation

Studies at this site

• A Phase Ib/II Study of LGX818 in Combination With MEK162 in Adult Patients With BRAF Dependent Advanced Solid Tumors — Completed
• Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence — Stopped early